Top-News
Pharmazeutika Schweiz

Idorsia News

Aktie
WKN:  A2DTEB ISIN:  CH0363463438 US-Symbol:  IDRSF
1,95 $
-0,35 $
-15,22%
30.04.24 15:35:43
Handeln Depot/Watchlist
Aktienanzahl *
188,26 Mio.
Marktkapitalisierung *
406,47 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 31.01.2024

Idorsia News

10.01.24 - GlobeNewswire
Idorsia presents at the J.P. Morgan Healthcare Conference – Adapting Idorsia for sustainable value creation
Ad hoc announcement pursuant to Art. 53 LR
10.01.24 - GlobeNewswire
Idorsia presents at the J.P. Morgan Healthcare Conference – Adapting Idorsia for sustainable value creation
Ad hoc announcement pursuant to Art. 53 LR
03.11.23 - GlobeNewswire
New Phase 3 data with aprocitentan for patients with resistant hypertension has been presented at the American Society of Nephrology Kidney Week 2023
Allschwil, Switzerland – November 3, 2023
03.11.23 - GlobeNewswire
New Phase 3 data with aprocitentan for patients with resistant hypertension has been presented at the American Society of Nephrology Kidney Week 2023
Allschwil, Switzerland – November 3, 2023
24.10.23 - GlobeNewswire
Idorsia announces financial results for the first nine months of 2023 – adapting the company to create sustainable value
Ad hoc announcement pursuant to Art. 53 LR
24.10.23 - GlobeNewswire
Idorsia gibt Finanzergebnisse für die ersten neun Monate 2023 bekannt – Anpassung des Unternehmens zur Schaffung von nachhaltigem Wert
Ad-​hoc-Mitteilung gemäss Art. 53 KR
23.10.23 - GlobeNewswire
Idorsia is committed to further the science of sleep with a symposium and poster presentations at World Sleep 2023
Allschwil, Switzerland – October 23, 2023
23.10.23 - GlobeNewswire
Idorsia is committed to further the science of sleep with a symposium and poster presentations at World Sleep 2023
Allschwil, Switzerland – October 23, 2023
17.10.23 - GlobeNewswire
Invitation to Idorsia's Nine-Month 2023 Financial Reporting webcast and conference call
Idorsia will publish its Nine-​Month Financial Reporting 2023 on Tuesday October 24, 2023, at 07:00 CEST.
17.10.23 - GlobeNewswire
Invitation to Idorsia's Nine-Month 2023 Financial Reporting webcast and conference call
Idorsia will publish its Nine-​Month Financial Reporting 2023 on Tuesday October 24, 2023, at 07:00 CEST.
06.09.23 - GlobeNewswire
Idorsia reacquires the world-wide rights to aprocitentan
Ad hoc announcement pursuant to Art. 53 LR
06.09.23 - GlobeNewswire
Idorsia reacquires the world-wide rights to aprocitentan
Ad hoc announcement pursuant to Art. 53 LR
25.07.23 - GlobeNewswire
Idorsia announces financial results for the first half 2023 – adapting the company to create sustainable value
Ad hoc announcement pursuant to Art. 53 LR
25.07.23 - GlobeNewswire
Idorsia gibt Finanzergebnisse für das erste Halbjahr 2023 bekannt – Anpassung des Unternehmens zur Schaffung von nachhaltigem Wert
Ad-​hoc-Mitteilung gemäss Art. 53 K R
21.07.23 - GlobeNewswire
Idorsia announces a cost reduction initiative to be implemented by the end of 2023
Ad hoc announcement pursuant to Art. 53 LR
21.07.23 - GlobeNewswire
Idorsia kündigt eine Kostensenkungsinitiative an, die bis Ende 2023 umgesetzt werden soll
Ad-​hoc-Mitteilung gemäss Art. 53 KR
20.07.23 - GlobeNewswire
Idorsia sells its Asia Pacific (ex-China) operations – including select license rights to products – to Sosei Heptares for a total consideration of CHF 400 million
Ad hoc announcement pursuant to Art. 53 LR
20.07.23 - GlobeNewswire
Idorsia sells its Asia Pacific (ex-China) operations – including select license rights to products – to Sosei Heptares for a total consideration of CHF 400 million
Ad hoc announcement pursuant to Art. 53 LR
18.07.23 - GlobeNewswire
Invitation to Idorsia's HY 2023 Financial Results webcast and conference call
Idorsia will publish its half year financial results 2023 on Tuesday July 25, 2023, at 07:00 CEST.
18.07.23 - GlobeNewswire
Invitation to Idorsia's HY 2023 Financial Results webcast and conference call
Idorsia will publish its half year financial results 2023 on Tuesday July 25, 2023, at 07:00 CEST.

Newssuche

Videos

newspaper
07.05.24 +6,80%
Technical Trading: DAX Long kurzfristig
DAX Long Typ: Turbo Open End WKN: NG8K9X Hebel: 26 Laufzeit: OpenEnd Einstieg: Market ... Mehr »